Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Miguel Angel Campanero"'
Autor:
Pau Arbos, Miguel Angel Campanero, Socorro Espuelas, Monica Konecny, MarÃÂa Huici, Juan M. Irache
Publikováno v:
Molecules, Vol 10, Iss 1, Pp 126-145 (2005)
Bioadhesive nanoparticles have been proposed as carriers for the oral delivery of poorly available drugs and facilitate the use of this route. This work summarises some experiments describing the bioadhesive potential of Gantrez nanoparticles fluores
Externí odkaz:
https://doaj.org/article/41bd6cafdd394a47a6523d819f8b1eb6
Autor:
Belen Sadaba, Anabel del Barrio, Miguel Angel Campanero, Jose Ramon Azanza, Almudena Gomez-Guiu, Jose Maria Lopez-Picazo, Salvador Martin Algarra, Francisco Guillén Grimá, Maria Blanco Prieto, Jose Luis Perez-Gracia, Alfonso Gurpide
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even though it co
Externí odkaz:
https://doaj.org/article/732bd83ce7fe475ebabe0fd50f2fd1e3
Autor:
Miguel Angel Campanero, Nicholas King, Nerea Leal, Estitxu Rico, Enriqueta Casal, Iker Navarro, Eider Alcaraz, Soledad Garcia-Martínez, Alba Grisaleña
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 150
Ambrisentan is a highly selective endothelin-1 type A receptor antagonist indicated for use in the treatment of pulmonary hypertension. In this study an assay was developed and validated for the quantification of total and unbound (free) concentratio
Autor:
Elisa Elizondo, Edurne Imbuluzqueta, Nora Ventosa, David Salas, Jaume Veciana, Hugo Lana, Miguel Angel Campanero, Carlos Gamazo, María J. Blanco-Prieto, Ana Gloria Gil
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
instname
The clinical management of human brucellosis is still challenging and demands in vitro active antibiotics capable of targeting the pathogen-harboring intracellular compartments. A sustained release of the antibiotic at the site of infection would mak
Autor:
Laura García-López, María José Fernández-Reyes, Belén Sádaba, José Ramón Azanza, Miguel Angel Campanero, María Asunción Parra, Ángel Irigoyen
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 33:458-461
Publikováno v:
Arzneimittelforschung. 58:283-287
Triflusal (CAS 322-79-2) is an antiplatelet agent related to salicylates used in several European and Latin American countries in the treatment of cardiovascular diseases. The aim of this paper was to evaluate the bioequivalence of triflusal derived
Autor:
Xabier Agirre, Miguel Angel Campanero, María J. Blanco-Prieto, A. Estella-Hermoso de Mendoza, Iturburua Izaskum Imbuluzqueta, David González, Felipe Prosper, Gloria Abizanda, Hugo Lana, Amaia Vilas-Zornoza
Publikováno v:
Journal of Chromatography B. 879:3490-3496
An ultra high performance liquid chromatography tandem mass spectrometry method (UHPLC-MS/MS) was developed and validated for the quantitation of LBH589, a novel histone deacetylase inhibitor (HDACi), in mouse plasma and tissues (liver, spleen, kidne
Autor:
Miguel Angel Campanero, A. Estella-Hermoso de Mendoza, María J. Blanco-Prieto, Faustino Mollinedo
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
The anti-tumor agent edelfosine represents a promising option in the treatment of cancer due to its capacity of promoting apoptosis in tumor cells selectively, while sparing healthy ones. In the present study, a novel ultra high performance liquid ch
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 50:649-654
A new method for the quantitative analysis of clindamycin in human plasma and saliva by liquid chromatography/electrospray ionisation tandem mass spectrometry (LC/ESI-MS/MS) has been developed using a rapid resolution C18 column (2.1 mm x 30 mm x 3.5
Autor:
Miguel Angel Campanero, María J. Blanco-Prieto, Faustino Mollinedo, Ander Estella-Hermoso de Mendoza
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately, most chemotherapy drugs cannot tell the difference between a cancer cell and a healthy cell. In this sense, some other drawbacks often encountered with antineopla